MIRD Pamphlet No. 24: Guidelines for Quantitative 131I SPECT in Dosimetry Applications
暂无分享,去创建一个
Michael Ljungberg | Eric C Frey | Yuni K Dewaraja | George Sgouros | Wesley E Bolch | Roger W Howell | Pat B Zanzonico | Barry W Wessels | B. Wessels | E. Frey | A. Brill | M. Ljungberg | P. Zanzonico | M. Dunphy | W. Bolch | G. Sgouros | R. Meredith | D. Fisher | R. Howell | Y. Dewaraja | Alan J Green | A Bertrand Brill | Mark Dunphy | Darrell R Fisher | Ruby F Meredith | A. Green
[1] Improved dose-volume histogram estimates for radiopharmaceutical therapy by optimizing quantitative SPECT reconstruction parameters. , 2013, Physics in medicine and biology.
[2] S. Wilderman,et al. Method for Fast CT/SPECT-Based 3D Monte Carlo Absorbed Dose Computations in Internal Emitter Therapy , 2007, IEEE Transactions on Nuclear Science.
[3] M S Rosenthal,et al. Quantitative SPECT imaging: a review and recommendations by the Focus Committee of the Society of Nuclear Medicine Computer and Instrumentation Council. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] Joachim Hornegger,et al. Quantitative Accuracy of Clinical 99mTc SPECT/CT Using Ordered-Subset Expectation Maximization with 3-Dimensional Resolution Recovery, Attenuation, and Scatter Correction , 2010, Journal of Nuclear Medicine.
[5] M. Kaminski,et al. Prediction of therapy tumor-absorbed dose estimates in I-131 radioimmunotherapy using tracer data via a mixed-model fit to time activity. , 2012, Cancer biotherapy & radiopharmaceuticals.
[6] M. Ljungberg,et al. A Monte Carlo program for the simulation of scintillation camera characteristics. , 1989, Computer methods and programs in biomedicine.
[7] K. Koral,et al. Deadtime correction for two multihead Anger cameras in 131I dual-energy-window-acquisition mode. , 1998, Medical physics.
[8] M. Gaze,et al. Dosimetry for fractionated (131)I-mIBG therapies in patients with primary resistant high-risk neuroblastoma: preliminary results. , 2007, Cancer biotherapy & radiopharmaceuticals.
[9] J. Fessler,et al. Regularized reconstruction in quantitative SPECT using CT side information from hybrid imaging , 2010, Physics in medicine and biology.
[10] Hanna Piwowarska-Bilska,et al. The accuracy and reproducibility of SPECT target volumes and activities estimated using an iterative adaptive thresholding technique , 2012, Nuclear medicine communications.
[11] Eric C Frey,et al. The impact of 3D volume of interest definition on accuracy and precision of activity estimation in quantitative SPECT and planar processing methods , 2010, Physics in medicine and biology.
[12] George Sgouros,et al. Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] D Front,et al. SPECT quantitation of iodine-131 concentration in phantoms and human tumors. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[15] S Shcherbinin,et al. Accuracy of quantitative reconstructions in SPECT/CT imaging , 2008, Physics in medicine and biology.
[16] Eric C Frey,et al. Development and evaluation of a model-based downscatter compensation method for quantitative I-131 SPECT. , 2011, Medical physics.
[17] H R Tang,et al. Neuroblastoma imaging using a combined CT scanner-scintillation camera and 131I-MIBG. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] E. Frey,et al. Effects of shortened acquisition time on accuracy and precision of quantitative estimates of organ activity. , 2010, Medical physics.
[19] M. Kaminski,et al. Use of integrated SPECT/CT imaging for tumor dosimetry in I-131 radioimmunotherapy: a pilot patient study. , 2009, Cancer biotherapy & radiopharmaceuticals.
[20] M H Loew,et al. Threshold estimation in single photon emission computed tomography and planar imaging for clinical radioimmunotherapy. , 1995, Cancer research.
[21] F. Berthold,et al. Dosimetry for 131I-MIBG therapies in metastatic neuroblastoma, phaeochromocytoma and paraganglioma , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[22] Yuni K Dewaraja,et al. 131I-Tositumomab Radioimmunotherapy: Initial Tumor Dose–Response Results Using 3-Dimensional Dosimetry Including Radiobiologic Modeling , 2010, Journal of Nuclear Medicine.
[23] Quantitation in 131 I‐radioimmunotherapy using spect , 1988, International journal of cancer. Supplement = Journal international du cancer. Supplement.
[24] High-resolution absolute SPECT quantitation for I-131 distributions used in the treatment of lymphoma: a phantom study , 2000 .
[25] A. Yendiki,et al. Comparison of 3-D OSEM versus 1-D SAGE for focal total-activity quantification in I-131 SPECT with HE collimation , 2005, IEEE Transactions on Nuclear Science.
[26] K. Kearfott,et al. Comparison of I-131 radioimmunotherapy tumor dosimetry: unit density sphere model versus patient-specific Monte Carlo calculations. , 2011, Cancer biotherapy & radiopharmaceuticals.
[27] Jm Pereira,et al. IMAGE QUANTIFICATION FOR RADIATION DOSE CALCULATIONS—LIMITATIONS AND UNCERTAINTIES , 2010, Health physics.
[28] Yuni K. Dewaraja,et al. MIRD Pamphlet No. 23: Quantitative SPECT for Patient-Specific 3-Dimensional Dosimetry in Internal Radionuclide Therapy , 2012, The Journal of Nuclear Medicine.